[The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
The pharmacological properties of a new drug approved in the USSR for the treatment of cholinolytics poisonings are described. The drug is as active as physostigmine. However, its action is longer. Aminostigmine exhibits marked central effects, which forms the basis for its use for elimination of brain dysfunctions caused by choline blockers.
Prozorovskiĭ
V B
VB
Pavlova
L V
LV
Suslova
I M
IM
Shchemeleva
N I
NI
D000009:Abdominal Muscles / Q000187:drug effects; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D002219:Carbamates; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D002802:Cholinesterases / Q000097:blood; D004285:Dogs; D006168:Guinea Pigs; D066298:In Vitro Techniques; D051379:Mice; D010830:Physostigmine / Q000494:pharmacology; D011725:Pyridines; D011729:Pyridostigmine Bromide / Q000031:analogs & derivatives; D011817:Rabbits; D011898:Ranidae; D051381:Rats; D001743:Urinary Bladder / Q000187:drug effects
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D011725:Pyridines; C070102:aminostigmine; D010830:Physostigmine; D002802:Cholinesterases; D011729:Pyridostigmine Bromide
Farmakologicheskaia kharakteristika novogo antikholinésteraznogo lekarstvennogo sredstva aminostigmina.